Topics

$VRTX Announces Positive Phase 2 Data in Third Proof-of-Concept Study with the NaV1.8 Inhibitor VX-150 https://www.businesswire.com/news/home/20181218005223/en/Vertex-Announces-Positive-Phase-2-Data-Proof-of-Concept …

08:37 EST 18 Dec 2018 | Odi Bruckman

Announces Positive Phase 2 Data in Third Proof-of-Concept Study with the NaV1.8 Inhibitor VX-150 https://www.businesswire.com/news/home/20181218005223/en/Vertex-Announces-Positive-Phase-2-Data-Proof-of-Concept …

Original Article: $VRTX Announces Positive Phase 2 Data in Third Proof-of-Concept Study with the NaV1.8 Inhibitor VX-150 https://www.businesswire.com/news/home/20181218005223/en/Vertex-Announces-Positive-Phase-2-Data-Proof-of-Concept …

NEXT ARTICLE

More From BioPortfolio on "$VRTX Announces Positive Phase 2 Data in Third Proof-of-Concept Study with the NaV1.8 Inhibitor VX-150 https://www.businesswire.com/news/home/20181218005223/en/Vertex-Announces-Positive-Phase-2-Data-Proof-of-Concept …"

Quick Search